SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen
1. Faruqi & Faruqi investigates potential claims against PepGen. 2. Class action deadline for investors is August 11, 2025. 3. Claims allege misleading statements about PGN-EDO51 and safety concerns. 4. PepGen's stock has fallen significantly due to FDA concerns. 5. Recent studies showed disappointing results in ongoing clinical trials.